GT Medical Technologies Company
%20.jpg)
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Founded Date:
2017-01-01
Total Funding:
$13M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
NeuroTech
Last Funding Type:
Series A
Investors Number:
4
Industry:
Health Care, Medical, Medical Device
Headquarters:
Tempe, Arizona, United States
Estimated Revenue:
$1M to $10M